NEW JERSEY HOSPITAL ASSOCIATION for NEW JERSEY HOSPITAL ASSOCIATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Support S. 3187, the Food and Drug Administration Safety and Innovation Act, which included industry supported provisions to help alleviate critical drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CHAMPI KRENIK | — |
Medicare/Medicaid MMM
Medicare: Advocated for a Congressional letter to CMS in support of NJHAs application to extend and expand our ongoing gainsharing pilot in New Jersey; Urged HHS to extend current relief from full implementation of the 25% rule affecting long-term care hospitals (LTCHs) for an additional hospital cost reporting period and/or at least until the end of 2012 in order to give Congress an opportunity to resolve many of the issues affecting LTCHs; Oppose any proposals to fund deficit reduction or other activities with additional cuts to Medicare and Medicaid providers; Oppose targeting cuts to health care programs to avert looming across the board budget cuts (sequestration). Proactively support the measures upholding policies that allow for geographic reclassification of New Jersey hospitals, extension of section 508 of the MMA, approving HIT payments to multi-hospital systems, support urban Medicare dependent hospitals payments, and continued funding for childrens hospitals graduate medical education. Support efforts to rescind proposed coding offset provisions included in CMS' FY 2013 proposed IPPS rule. This proposed provision combines a 2.7 percent reduction to the market basket for documentation and coding adjustments, which is comprised of 1.9 percent for 2008 and 2009 and 0.8 percent for 2010.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CHAMPI KRENIK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.